Journey Through Words: Exploring Esophageal Cancer in Literature.

Autor:	Shahid MH; Surgery, Glangwili General Hospital, Carmarthen, GBR., Mithany RH; Laparoscopic Colorectal Surgery, Kingston Hospital National Health Service (NHS) Foundation Trust, Kingston, GBR., Aslam S; General Surgery, Lahore General Hospital, Lahore, PAK., Daniel N; Medical Laboratory Science, Ain Shams University, Cairo, EGY., Gerges F; General and Emergency Surgery, Kingston Hospital National Health Service (NHS) Foundation Trust, Kingston, GBR., Gill MU; Accident and Emergency, King's College Hospital National Health Service (NHS) Foundation Trust, London, GBR., Wanees A; General Surgery, Dar El-Salam General Hospital, Cairo, EGY., Abdallah S; Surgery, Jaber Al-Ahmad Hospital, Kuwait City, KWT., Abdelmaseeh M; General Surgery, Faculty of Medicine, Assuit University, Assuit, EGY., Hannan A; Surgery, Glangwili General Hospital, Carmarthen, GBR.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Nov 06; Vol. 15 (11), pp. e48411. Date of Electronic Publication: 2023 Nov 06 (Print Publication: 2023).
DOI:	10.7759/cureus.48411
Abstrakt:	Esophageal cancer is a significant global health challenge, characterized by its aggressive nature and high mortality rates. The disease disproportionately affects males and ranks among the leading causes of cancer-related deaths worldwide. Alarming projections indicate that the prevalence of esophageal cancer is expected to surge by approximately 140% by the year 2025. This trend starkly contrasts with the anticipated decline in incidence observed for many other types of cancers. The cancer manifests primarily in two major subtypes: esophageal squamous cell carcinoma and adenocarcinoma, each with distinct epidemiological and biological characteristics. This review provides an in-depth exploration of the risk factors, anatomy, clinical presentation, diagnosis, staging, prognosis, treatment modalities, recurrence, advancements, and emerging therapies in esophageal cancer. Additionally, preventive and early detection strategies are discussed, focusing on primary, secondary, and tertiary prevention approaches. A comprehensive understanding of esophageal cancer is vital for formulating effective management strategies and improving patient outcomes. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Shahid et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu